Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism EHMT2 inhibitors(euchromatic histone lysine methyltransferase 2 inhibitors), H3K9me3 inhibitors(Histone 3 lysine 9 trimethylation protein inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H41N5O3 |
InChIKeyFNRUPVONTWZCGL-UHFFFAOYSA-N |
CAS Registry2866408-21-9 |